Avita Medical Stock Today
| RCEL Stock | USD 5.20 0.13 2.44% |
PerformanceWeak
| Odds Of DistressRisky
|
Avita Medical is selling for 5.20 as of the 26th of September 2025. This is a 2.44 percent decrease since the beginning of the trading day. The stock's lowest day price was 5.15. Avita Medical has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 28th of June 2025 and ending today, the 26th of September 2025. Click here to learn more.
AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 27.02 M outstanding shares of which 4.53 M shares are at this time shorted by private and institutional investors with about 10.99 trading days to cover. More on Avita Medical
Moving against Avita Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Avita Stock Highlights
| President CEO | James Corbett |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
Avita Medical (RCEL) is traded on NASDAQ Exchange in USA. It is located in 28159 Avenue Stanford, Valencia, CA, United States, 91355 and employs 260 people. Avita Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 144.01 M. Avita Medical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 27.02 M outstanding shares of which 4.53 M shares are at this time shorted by private and institutional investors with about 10.99 trading days to cover.
Avita Medical currently holds about 84.17 M in cash with (48.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Check Avita Medical Probability Of Bankruptcy
Ownership AllocationAvita Medical holds a total of 27.02 Million outstanding shares. Almost 69.91 percent of Avita Medical outstanding shares are held by general public with 0.91 (percent) owned by insiders and only 29.18 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avita Ownership Details
Avita Medical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Avita Medical market risk premium is the additional return an investor will receive from holding Avita Medical long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0299 | |||
| Jensen Alpha | 0.0114 | |||
| Total Risk Alpha | (1.10) | |||
| Sortino Ratio | 0.0289 |
Avita Stock Against Markets
Avita Medical Corporate Management
| Rob Hall | Senior Resources | Profile | |
| David Melbye | Senior Operations | Profile | |
| Michael MBA | Chief Officer | Profile | |
| Jessica Ekeberg | Investor Executive | Profile | |
| Robin VanDenburgh | Senior Sales | Profile | |
| David OToole | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in commodities. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.